News | December 02, 2025
Lilly slashes prices on Zepbound vials to expanding access to obesity treatment
Patients can now get the starting 2.5 mg dose for $299 per month
Patients can now get the starting 2.5 mg dose for $299 per month
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Renalyx will continue operating as an independent unit within the group
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Investment to expand manufacturing and global medicine supply capacity
Subscribe To Our Newsletter & Stay Updated
